ADO ASX · Materials

Anteotech Ltd

Announcements, last 12 months: 74
Price sensitive, last 12 months: 17

Latest announcements

Released	Headline	Actions
22 Oct 2026, 9:27 AM	ADO October 2026 Investor Presentation
14 Oct 2026, 9:28 AM	AnteoTech Company Presentation - The Battery Show
7 Oct 2026, 9:35 AM	Notice of Annual General Meeting/Proxy Form
30 Sep 2026, 9:16 AM	Full Year Results and Business Update Presentation Price sensitive	AI summary
29 Sep 2026, 3:19 PM	$1.9 million R&D Tax Incentive Received Price sensitive	AI summary
28 Sep 2026, 9:14 AM	FY2026 Corporate Governance Statement and Appendix 4G
28 Sep 2026, 9:04 AM	Annual Report to shareholders
24 Sep 2026, 9:13 AM	Notification regarding unquoted securities - ADO
23 Sep 2026, 9:16 AM	FY26 Results Investor Webinar
18 Sep 2026, 9:06 AM	2026 Annual General Meeting date

Sign in to see all ADO announcements.

Guidance history

20 Jul 2026	A$10.0 million raised from option exercise, A$61,595 in CLIA-related revenue
29 May 2026	Raising up to $10,000,000 from underwriting agreement.
29 Dec 2025	The company expects further sales to SII this financial year. The ELISA market segment represents approximately 40% of the global immunoassays market, valued at US$21 billion and forecast to grow at 5% CAGR through to 2029. The CLIA market is estimated to have a value of US$13 billion and is forecast to grow at around 6% CAGR through to 2029.

Sign in to see the full guidance history.

Most followed in Materials

BHP BHP Group Ltd
PLS PLS Group Ltd
VYS Vysarn Ltd
MIN Mineral Resources Ltd
NST Northern Star Resources Ltd
RMS Ramelius Resources Ltd
EVN Evolution Mining Ltd
RIO RIO Tinto Ltd

Follow ADO to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.